Search
                    Cisplatin Treatment Options in Massachusetts
A collection of 335 research studies where Cisplatin is the interventional treatment. These studies are located in the Massachusetts, United States. Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-Small Cell Lung Cancer.
            277 - 288 of 335
        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
                                
            
            
        Completed
                            
            
                The purpose of this study it to determine the safety and maximally tolerated dose (MTD) of cisplatin administered in the operating room and put into the chest and abdomen for one hour. We are also looking at the effects of heating the chemotherapy to a temperature of 42 degrees celsius.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                03/26/2014
            
            Locations: Brigham and Women's Hospital, Boston, Massachusetts  +1 locations         
        
        
            Conditions: Pleural Mesothelioma, Malignant Pleural Mesothelioma
        
            
        
    
                
                                    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which treatment regimen is more effective for endometrial cancer.
PURPOSE: Randomized phase III trial to compare radiation therapy with chemotherapy in treating patients who have advanced endometrial cancer.             
        
        
    Gender:
                FEMALE
            Ages:
                All
            Trial Updated:
                02/12/2014
            
            Locations: University of Massachusetts Memorial Medical Center, Worcester, Massachusetts         
        
        
            Conditions: Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment
        
            
        
    
                
                                    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed neuroblastoma.             
        
        
    Gender:
                ALL
            Ages:
                30 years and below
            Trial Updated:
                02/12/2014
            
            Locations: Floating Hospital for Children, Boston, Massachusetts  +1 locations         
        
        
            Conditions: Neuroblastoma
        
            
        
    
                
                                    Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known if chemotherapy plus radiation therapy is more effective than radiation therapy alone in treating patients with advanced cancer of the larynx.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients with advanced c...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                01/23/2014
            
            Locations: New England Medical Center Hospital, Boston, Massachusetts  +1 locations         
        
        
            Conditions: Head and Neck Cancer
        
            
        
    
                
                                    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of radiation therapy plus combination chemotherapy in treating patients with limited-stage small cell lung cancer.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                10/31/2013
            
            Locations: Cape Cod Hospital, Hyannis, Massachusetts  +1 locations         
        
        
            Conditions: Lung Cancer
        
            
        
    
                
                                    Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy, such as docetaxel, cisplatin, fluorouracil, and carboplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. It is not yet known which regimen of chemotherapy and radiation therapy is most effective in treating head and neck cancer.
PURPOSE: Randomized phase III trial to compare the...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/25/2013
            
            Locations: Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts         
        
        
            Conditions: Head and Neck Cancer
        
            
        
    
                
                                    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effect on the body of combining cyclophosphamide with cisplatin, etoposide, and bleomycin in treating children who have newly diagnosed malignant germ cell tumors that are not in the brain and gonads.             
        
        
    Gender:
                ALL
            Ages:
                21 years and below
            Trial Updated:
                10/15/2013
            
            Locations: Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts         
        
        
            Conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
        
            
        
    
                
                                    Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
                                
            
            
        Completed
                            
            
                This study is testing the investigational drug, cetuximab, in combination with different chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug combinations looks most promising and should be tested further. The study will also look at what side effects may occur.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/11/2013
            
            Locations: Not set, Springfield, Massachusetts  +1 locations         
        
        
            Conditions: Non-Small Cell Lung Cancer
        
            
        
    
                
                                    Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
                                
            
            
        Completed
                            
            
                This study will gather and compare data about the effectiveness and safety of two different treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received previous chemotherapy. One treatment will use an investigational drug in combination with an FDA approved chemotherapy. The other treatment will use a combination of two FDA approved chemotherapy drugs.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/20/2013
            
            Locations: GSK Clinical Trials Call Center, Pittsfield, Massachusetts         
        
        
            Conditions: Small Cell Lung Cancer
        
            
        
    
                
                                    ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
                                
            
            
        Withdrawn
                            
            
                RATIONALE: A specially modified virus called ONYX-015 may be able to kill tumor cells while leaving normal cells undamaged. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining ONYX-015 with chemotherapy may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of ONYX-015 combined with cisplatin and fluorouracil in treating patients who have advanced head and neck cancer.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 79 years
            Trial Updated:
                07/09/2013
            
            Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts  +1 locations         
        
        
            Conditions: Lip and Oral Cavity Cancer, Head and Neck Cancer, Oropharyngeal Cancer
        
            
        
    
                
                                    Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy drugs before surgery may shrink the tumor so that it can be removed during surgery.
PURPOSE: Randomized phase III trial to compare surgery with or without chemotherapy in treating patients who have stage IB cervical cancer.             
        
        
    Gender:
                FEMALE
            Ages:
                All
            Trial Updated:
                07/08/2013
            
            Locations: Tufts University School of Medicine, Boston, Massachusetts  +1 locations         
        
        
            Conditions: Cervical Cancer
        
            
        
    
                
                                    Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug or combining chemotherapy with surgery may kill more tumor cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy consisting of paclitaxel and cisplatin with or without surgery in treating patients with stage III ovarian epithelial cancer.             
        
        
    Gender:
                FEMALE
            Ages:
                All
            Trial Updated:
                07/08/2013
            
            Locations: University of Massachusetts Memorial Medical Center, Worcester, Massachusetts         
        
        
            Conditions: Ovarian Cancer
        
            
        
    277 - 288 of 335
            